Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

NCT00000318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Buprenorphine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]